Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

14.15
Delayed Data
As of Dec 02
 +0.35 / +2.54%
Today’s Change
7.86
Today|||52-Week Range
17.63
-4.65%
Year-to-Date

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for Momenta Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 20.00 and a low estimate of 6.00. The median estimate represents a -1.06% decrease from the last price of 14.15.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Momenta Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.23
Sales
$29.1M
Reporting Date
Feb 21

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 10.01%
 
 
 
 
 
 
Growthannually 14.26%
 
 
 
 
 
 

Sales

Growthquarterly -0.07%
 
 
 
 
 
 
Growthannually 17.03%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.